openPR Logo
Press release

Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031

05-05-2025 11:06 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing marke

According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing marke

According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031.
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD) testing.

A more than 150-page report to understand trends, opportunity and forecast in MRD testing market to 2031 by technology (flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS), and others), application (hematological malignancies, leukemia, lymphoma, solid tumors, and others), end use industry (hospitals and specialty clinics, diagnostic laboratories, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Lucintel forecasts that Polymerase Chain Reaction (PCR) is expected to witness highest growth over the forecast period.

Within this market, hospitals and specialty clinics will remain the largest segment.

Download sample by clicking on MRD testing market

APAC is expected to witness highest growth over the forecast period.

Labcorp, F. Hoffmann-La Roche, Guardant Health, Sysmex Corporation, Neogenomics Laboratories, Adaptive Biotechnologies Corporation, Archerdx, Asuragen, Arup Laboratories are the major suppliers in the MRD testing market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact: Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. +1-972-636-5056

Explore Our Latest Publications

Hi-Fi System Market

Bearing for Mechanical and Electrical Product

Telecom Electronic Manufacturing Service Market

Timing Device Market

Visual Inspection Microscope Market

Construction Waste Crusher Market

Nonwovens for Construction Market

OSB Panel for Construction Market

Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=lucintel-forecasts-the-global-mrd-testing-market-to-reach-34-billion-by-2031]
Phone: 972.636.5056
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031 here

News-ID: 4000115 • Views:

More Releases from ABNewswire

DelveInsight projects the Pulsed Lavage Devices Market to grow at a CAGR of 8.35% through 2032
DelveInsight projects the Pulsed Lavage Devices Market to grow at a CAGR of 8.35 …
The global pulsed lavage devices market was valued at USD 479.87 million in 2024, growing at a CAGR of 8.35% during the forecast period from 2025 to 2032 to reach USD 906.40 million by 2032. The overall market for pulsed lavage devices is being significantly boosted by several factors. The rising number of orthopedic surgeries, trauma cases, and chronic wounds such as diabetic ulcers and pressure sores has heightened the
Crohn's Disease Outlook Report 2025: Promising Drugs and MOA Innovations Reshape Future Treatment Approaches | DelveInsight
Crohn's Disease Outlook Report 2025: Promising Drugs and MOA Innovations Reshape …
DelveInsight's, "Crohn's Disease Pipeline Insight 2025" report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in Crohn's Disease pipeline landscape. It covers the Crohn's Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Crohn's Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Spinal Cord Injury Pipeline Outlook Report 2025: Promising Drugs and MOA Innovations Reshape Future Treatment Approaches | DelveInsight
Spinal Cord Injury Pipeline Outlook Report 2025: Promising Drugs and MOA Innovat …
DelveInsight's "Spinal Cord Injury Pipeline Insight 2025" report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Spinal Cord Injury pipeline landscape. It covers the Spinal Cord Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Spinal Cord Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious
Triple Negative Breast Cancer Pipeline Outlook Report 2025: Promising Drugs and MOA Innovations Reshape Future Treatment Approaches | DelveInsight
Triple Negative Breast Cancer Pipeline Outlook Report 2025: Promising Drugs and …
DelveInsight's "Triple Negative Breast Cancer Pipeline Insight 2025" report provides comprehensive insights about 165+ companies and 170+ pipeline drugs in the Triple Negative Breast Cancer pipeline landscape. It covers the Triple Negative Breast Cancer Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Triple Negative Breast Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline

All 5 Releases


More Releases for MRD

Minimal Residual Disease (MRD) Testing Market Demand in 2034
Rising adoption of next-generation sequencing (NGS), expanded use of MRD in hematologic malignancies, and growing integration of liquid biopsy technologies are propelling strong global market growth. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/50110 Introduction The Minimal Residual Disease (MRD) Testing Market is expanding rapidly as oncologists and diagnostic laboratories increasingly rely on highly sensitive molecular tests to detect trace levels of cancer cells that persist after treatment. MRD testing-using flow
Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing
MRD Testing Market Report: Trends, Forecast and Competitive Analysis to 2031
The future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 with a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology
Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing
Global MRD Testing Market Set to Reach USD 3.72 Billion by 2030
➤ Global Minimal Residual Disease (MRD) Testing Market to Reach USD 3.72 Billion by 2030, Driven by Technological Advancements and Rising Cancer Incidence The global Minimal Residual Disease (MRD) Testing Market is projected to expand from USD 1.60 billion in 2023 to USD 3.72 billion by 2030, registering a robust Compound Annual Growth Rate (CAGR) of 12.8% during the forecast period. ➤ Competitive Landscape and Regional Demand The MRD testing market
MRD Testing  Market Projected To Witness Substantial Growth, 2024-2031
The Latest research report on the MRD Testing Market 2024 provides a comprehensive analysis of the current market landscape, with forecasts extending to 2031. This study combines qualitative and quantitative insights to highlight significant market developments, challenges, competitive dynamics, and potential opportunities and trends shaping the MRD Testing Market. The report covers market size, recent trends, growth projections, market share, and development status. Additionally, it examines government policies,